Neuroleptic malignant syndrome in patients with COVID-19

We report the first two cases of Coronavirus Disease 2019 (COVID-19) who were receiving intensive care including favipiravir, and were clinically diagnosed with neuroleptic malignant syndrome (NMS) to focus attention on NMS in COVID-19 management. Case 1: A 46-year-old-man with acute respiratory dis...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Am J Emerg Med
Autori principali: Soh, Mitsuhito, Hifumi, Toru, Isokawa, Shutaro, Shimizu, Masato, Otani, Norio, Ishimatsu, Shinichi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Inc. 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7242930/
https://ncbi.nlm.nih.gov/pubmed/32473756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajem.2020.05.042
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi